Mutaz Jamal Al‐Khreisat

4 ta ish

Amman Private University

1. Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms

   Amr Ali Mohamed Abdelgawwad El-Sehrawy, Mutaz Jamal Al‐Khreisat, Makhfirat Kibriyeva +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.037165

2. Epigenetic Rewiring and Context‐Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms

   Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mutaz Jamal Al‐Khreisat, Aziz Kubaev +5

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.048787

3. Hypoxia-induced epigenetic reprogramming of cancer stem cells: Linking stemness, metastasis, and therapy resistance

   Mutaz Jamal Al‐Khreisat, Rustam Narzikulov, Omer Qutaiba B. Allela +5

   Sharh maqola20260 iqtibos

   ABIABI:AkademIndex/2026.review-article.000221

4. Convergent node, divergent failure: GPX4–SLC7A11–GSH ferroptosis as a unifying, tissue-decoded axis of diabetic complications

   Mutaz Jamal Al‐Khreisat, Sarah Qutayba Badraldin, Jasur Rizaev +4

   Sharh maqola20260 iqtibos

   ABIABI:AkademIndex/2026.review-article.000223